Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
[What is the cost of health inequalities?].

Lakartidningen

Gerdtham UG, Lyttkens CH.
PMID: 24437107
Lakartidningen. 2013 Nov 20-26;110(47):2124.

No abstract available.

Cite
Gerdtham UG, Lyttkens CH. Vad kostar ojämlikhet i hälsa? [What is the cost of health inequalities?]. Lakartidningen. 2013;110(47):2124
Gerdtham, U. G., & Lyttkens, C. H. (2013). Vad kostar ojämlikhet i hälsa? [What is the cost of health inequalities?]. Lakartidningen, 110(47), 2124.
Gerdtham, Ulf-G, and Lyttkens, Carl Hampus. "Vad kostar ojämlikhet i hälsa?" [What is the cost of health inequalities?]. Lakartidningen vol. 110,47 (2013): 2124.
Gerdtham UG, Lyttkens CH. Vad kostar ojämlikhet i hälsa? [What is the cost of health inequalities?]. Lakartidningen. 2013 Nov 20-26;110(47):2124. Swedish. PMID: 24437107.
Copy Download .nbib Format: NLM
Uncertainty aversion-a reply to oliver.

Health economics

Andersson F, Lyttkens CH.
PMID: 10790704
Health Econ. 2000 Apr;9(3):257-9. doi: 10.1002/(sici)1099-1050(200004)9:3<257::aid-hec507>3.0.co;2-1.

No abstract available.

Cite
Andersson F, Lyttkens CH. Uncertainty aversion-a reply to oliver. Health Econ. 2000;9(3):257-9doi: 10.1002/(sici)1099-1050(200004)9:3<257::aid-hec507>3.0.co;2-1.
Andersson, F., & Lyttkens, C. H. (2000). Uncertainty aversion-a reply to oliver. Health economics, 9(3), 257-9. https://doi.org/10.1002/(sici)1099-1050(200004)9:3<257::aid-hec507>3.0.co;2-1
Andersson, and Lyttkens. "Uncertainty aversion-a reply to oliver." Health economics vol. 9,3 (2000): 257-9. doi: https://doi.org/10.1002/(sici)1099-1050(200004)9:3<257::aid-hec507>3.0.co;2-1
Andersson F, Lyttkens CH. Uncertainty aversion-a reply to oliver. Health Econ. 2000 Apr;9(3):257-9. doi: 10.1002/(sici)1099-1050(200004)9:3<257::aid-hec507>3.0.co;2-1. PMID: 10790704.
Copy Download .nbib Format: NLM
Societal costs of air pollution-related health hazards: A review of methods and results.

Cost effectiveness and resource allocation : C/E

Pervin T, Gerdtham UG, Lyttkens CH.
PMID: 18786247
Cost Eff Resour Alloc. 2008 Sep 11;6:19. doi: 10.1186/1478-7547-6-19.

This paper aims to provide a critical and systematic review of the societal costs of air pollution-related ill health (CAP), to explore methodological issues that may be important when assessing or comparing CAP across countries and to suggest ways...

Cite
Pervin T, Gerdtham UG, Lyttkens CH. Societal costs of air pollution-related health hazards: A review of methods and results. Cost Eff Resour Alloc. 2008;6:19doi: 10.1186/1478-7547-6-19.
Pervin, T., Gerdtham, U. G., & Lyttkens, C. H. (2008). Societal costs of air pollution-related health hazards: A review of methods and results. Cost effectiveness and resource allocation : C/E, 619. https://doi.org/10.1186/1478-7547-6-19
Pervin, Tanjima, et al. "Societal costs of air pollution-related health hazards: A review of methods and results." Cost effectiveness and resource allocation : C/E vol. 6 (2008): 19. doi: https://doi.org/10.1186/1478-7547-6-19
Pervin T, Gerdtham UG, Lyttkens CH. Societal costs of air pollution-related health hazards: A review of methods and results. Cost Eff Resour Alloc. 2008 Sep 11;6:19. doi: 10.1186/1478-7547-6-19. PMID: 18786247; PMCID: PMC2553058.
Copy Download .nbib Format: NLM
Complete metabolic response with [.

BJU international

Abrahamsson J, Kollberg P, Almquist H, Bläckberg M, Brändstedt J, Lyttkens K, Simoulis A, Sjödahl G, Sörenby A, Trägårdh E, Liedberg F.
PMID: 33626220
BJU Int. 2021 Feb 24; doi: 10.1111/bju.15374. Epub 2021 Feb 24.

OBJECTIVE: To determine whether repeated [PATIENTS AND METHODS: Between 2007 and 2018, 86 patients with clinically lymph node (LN)-positive bladder cancer (T1-T4, N1-N3, M0-M1a) were included and underwent a repeated FDG-PET-CT during cisplatin-based induction chemotherapy. The 71 patients that...

Cite
Abrahamsson J, Kollberg P, Almquist H, et al. Complete metabolic response with [. BJU Int. 2021;doi: 10.1111/bju.15374.
Abrahamsson, J., Kollberg, P., Almquist, H., Bläckberg, M., Brändstedt, J., Lyttkens, K., Simoulis, A., Sjödahl, G., Sörenby, A., Trägårdh, E., & Liedberg, F. (2021). Complete metabolic response with [. BJU international, . https://doi.org/10.1111/bju.15374
Abrahamsson, Johan, et al. "Complete metabolic response with [." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15374
Abrahamsson J, Kollberg P, Almquist H, Bläckberg M, Brändstedt J, Lyttkens K, Simoulis A, Sjödahl G, Sörenby A, Trägårdh E, Liedberg F. Complete metabolic response with [. BJU Int. 2021 Feb 24; doi: 10.1111/bju.15374. Epub 2021 Feb 24. PMID: 33626220.
Copy Download .nbib Format: NLM
Complete metabolic response with [.

BJU international

Abrahamsson J, Kollberg P, Almquist H, Bläckberg M, Brändstedt J, Lyttkens K, Simoulis A, Sjödahl G, Sörenby A, Trägårdh E, Liedberg F.
PMID: 33626220
BJU Int. 2021 Feb 24; doi: 10.1111/bju.15374. Epub 2021 Feb 24.

OBJECTIVE: To determine whether repeated [PATIENTS AND METHODS: Between 2007 and 2018, 86 patients with clinically lymph node (LN)-positive bladder cancer (T1-T4, N1-N3, M0-M1a) were included and underwent a repeated FDG-PET-CT during cisplatin-based induction chemotherapy. The 71 patients that...

Cite
Abrahamsson J, Kollberg P, Almquist H, et al. Complete metabolic response with [. BJU Int. 2021;doi: 10.1111/bju.15374.
Abrahamsson, J., Kollberg, P., Almquist, H., Bläckberg, M., Brändstedt, J., Lyttkens, K., Simoulis, A., Sjödahl, G., Sörenby, A., Trägårdh, E., & Liedberg, F. (2021). Complete metabolic response with [. BJU international, . https://doi.org/10.1111/bju.15374
Abrahamsson, Johan, et al. "Complete metabolic response with [." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15374
Abrahamsson J, Kollberg P, Almquist H, Bläckberg M, Brändstedt J, Lyttkens K, Simoulis A, Sjödahl G, Sörenby A, Trägårdh E, Liedberg F. Complete metabolic response with [. BJU Int. 2021 Feb 24; doi: 10.1111/bju.15374. Epub 2021 Feb 24. PMID: 33626220.
Copy Download .nbib Format: NLM
Time to disable DALYs? On the use of disability-adjusted life-years in health policy.

The European journal of health economics : HEPAC : health economics in prevention and care

Lyttkens CH.
PMID: 15609185
Eur J Health Econ. 2003 Sep;4(3):195-202. doi: 10.1007/s10198-003-0169-2. Epub 2003 Jul 01.

The concept of disability-adjusted life years (DALYs) has rapidly gained in popularity in health policy, and considerable research resources are being allocated to this field. Proponents of DALYs suggest that the measure can be used both as a "gross...

Cite
Lyttkens CH. Time to disable DALYs? On the use of disability-adjusted life-years in health policy. Eur J Health Econ. 2003;4(3):195-202doi: 10.1007/s10198-003-0169-2.
Lyttkens, C. H. (2003). Time to disable DALYs? On the use of disability-adjusted life-years in health policy. The European journal of health economics : HEPAC : health economics in prevention and care, 4(3), 195-202. https://doi.org/10.1007/s10198-003-0169-2
Lyttkens, Carl Hampus. "Time to disable DALYs? On the use of disability-adjusted life-years in health policy." The European journal of health economics : HEPAC : health economics in prevention and care vol. 4,3 (2003): 195-202. doi: https://doi.org/10.1007/s10198-003-0169-2
Lyttkens CH. Time to disable DALYs? On the use of disability-adjusted life-years in health policy. Eur J Health Econ. 2003 Sep;4(3):195-202. doi: 10.1007/s10198-003-0169-2. Epub 2003 Jul 01. PMID: 15609185.
Copy Download .nbib Format: NLM
[Unworthy behavior of the Swedish Medical Association].

Lakartidningen

Lyttkens L.
PMID: 23662544
Lakartidningen. 2013 Apr 10-16;110(15):775.

No abstract available.

Cite
Lyttkens L. Ovärdigt agerande av Läkarförbundet. [Unworthy behavior of the Swedish Medical Association]. Lakartidningen. 2013;110(15):775
Lyttkens, L. (2013). Ovärdigt agerande av Läkarförbundet. [Unworthy behavior of the Swedish Medical Association]. Lakartidningen, 110(15), 775.
Lyttkens, Leif. "Ovärdigt agerande av Läkarförbundet." [Unworthy behavior of the Swedish Medical Association]. Lakartidningen vol. 110,15 (2013): 775.
Lyttkens L. Ovärdigt agerande av Läkarförbundet. [Unworthy behavior of the Swedish Medical Association]. Lakartidningen. 2013 Apr 10-16;110(15):775. Swedish. PMID: 23662544.
Copy Download .nbib Format: NLM
Pre-treatment .

European journal of hybrid imaging

Kjölhede H, Almquist H, Lyttkens K, Bratt O.
PMID: 30148254
Eur J Hybrid Imaging. 2018;2(1):16. doi: 10.1186/s41824-018-0034-2. Epub 2018 Aug 07.

BACKGROUND: The aim of this study was to determine whether lymph node metastasis on pre-treatment RESULTS: Of 174 eligible men, 124 met the criteria for inclusion. The PET/CT scan was negative for metastasis in 97 (78%) men, inconclusive in...

Cite
Kjölhede H, Almquist H, Lyttkens K, et al. Pre-treatment . Eur J Hybrid Imaging. 2018;2(1):16doi: 10.1186/s41824-018-0034-2.
Kjölhede, H., Almquist, H., Lyttkens, K., & Bratt, O. (2018). Pre-treatment . European journal of hybrid imaging, 2(1), 16. https://doi.org/10.1186/s41824-018-0034-2
Kjölhede, Henrik, et al. "Pre-treatment ." European journal of hybrid imaging vol. 2,1 (2018): 16. doi: https://doi.org/10.1186/s41824-018-0034-2
Kjölhede H, Almquist H, Lyttkens K, Bratt O. Pre-treatment . Eur J Hybrid Imaging. 2018;2(1):16. doi: 10.1186/s41824-018-0034-2. Epub 2018 Aug 07. PMID: 30148254; PMCID: PMC6097795.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries